Shaanxi Kang Hui Pharmaceutical Co., Ltd. has strong scientific research strength, mature pharmaceutical technology, advanced production equipment and sophisticated testing instruments. It has a group of high-quality management talents and R&D teams such as medical experts, professors, doctors, masters and EMBA, and has established a stable cooperative relationship with many domestic scientific research institutes, schools and research institutes in Industry-University-Research, and has achieved remarkable scientific research results, with a cumulative investment of more than 30 million yuan, and has successively developed new drugs with exclusive intellectual property rights such as Xiaoke Capsule, Jizhi Capsule, Taitai Capsule and Yuanshengtong Capsule. The scientific research project of "Jiedu Qingfei Dripping Pills' National Five-class New Drugs (formerly National Second-class New Drugs)' for the treatment of viral infectious diseases-viral pneumonia" jointly researched by Shaanxi Kang Hui Pharmaceutical Co., Ltd., Beijing Sino-Japanese Friendship Hospital and Shaanxi College of Traditional Chinese Medicine has been supported by major scientific and technological projects of the Ministry of Science and Technology. Qiyao Xiaoke Capsule was supported by a major scientific and technological project of Shaanxi Province (13 1 15). The company has won more than 40 national, provincial and municipal honors. The core competitiveness of enterprises has been further enhanced, which has injected new vitality into the rapid development of enterprises.